Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.
Département d'Oncologie Médicale, Centre Oscar Lambret, Lille, France. hollebecque@yahoo.fr
Antoine
A
Hollebecque
Antoine
A
Adenis
Sophie
S
Taieb
Claudia
C
Lebedinsky
Nicolas
N
Penel
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D004149:Dioxoles / Q000627:therapeutic use*; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use*; D000077606:Trabectedin; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D004149:Dioxoles; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin